Smart ring manufacturer Ultrahuman has secured INR 100 Cr (USD 11.2 Mn) in venture debt from Alteria Capital, marking a significant step in its global expansion strategy. The Bengaluru-based wearable tech startup plans to leverage this fresh infusion to scale product innovation, enhance software-led revenue streams, and deepen partnerships across sports and academic research sectors. The funding comes at a crucial moment as Ultrahuman navigates both rapid growth and an intense legal battle in its largest market, the United States.
Founded by Mohit Kumar, Ultrahuman has been steadily strengthening its position in the global smart wearables market with products like the Ultrahuman Ring Air, Cyborg, and its metabolic health-focused ecosystem. These offerings combine hardware innovation with advanced software analytics to give users detailed insights into health, recovery, sleep, and performance. With the new venture debt, the company plans to accelerate development timelines, introduce more advanced features, and expand across new geographies.
Read Also :- MasterChow Targets 3X Revenue Growth by FY26, Plans Aggressive Offline Expansion
In an official statement, CEO Mohit Kumar emphasized Ultrahuman’s commitment to cost discipline, even as the company prepares to enter a faster growth phase. He noted that maintaining a lean operational model is key to strengthening long-term sustainability and innovation capability. This focus on cost efficiency is especially important as Ultrahuman invests heavily in R&D and builds out global partnerships in sports performance and scientific research.
However, the timing of this new funding is particularly significant due to Ultrahuman’s ongoing legal dispute with its Finnish competitor, Oura, known for pioneering the smart ring category. Oura has accused Ultrahuman of infringing on several of its patents related to smart ring technology. The legal tensions escalated in 2024, culminating in a full-fledged import and sales ban on Ultrahuman smart rings in the United States. This ban affects Ultrahuman’s access to what is not only its biggest market but also the most competitive and lucrative region for wearable technology brands.
Despite these challenges, Ultrahuman continues to grow rapidly in markets across Asia, the Middle East, and Europe. The startup has doubled down on innovation, expanding into areas such as continuous glucose monitoring (CGM) and integrated health intelligence platforms. By building a comprehensive ecosystem that blends hardware, software, and actionable health insights, Ultrahuman aims to differentiate itself in an increasingly crowded wearables landscape.
The latest round of venture debt signals strong investor confidence in the company’s vision and resilience. Alteria Capital’s backing also indicates belief in the long-term potential of the smart ring segment, which is projected to grow significantly as consumers adopt health-monitoring wearables beyond traditional smartwatches.
As Ultrahuman scales its product offerings and strengthens its global footprint, the outcome of its legal fight with Oura will remain a critical factor in its long-term strategy. Still, with robust funding, a disciplined growth plan, and a focus on innovation, Ultrahuman is positioning itself as a formidable player in the future of wearable health technology.
Leave a comment